To this end, we have analyzed WM and DLBCL cell lines endogenously expressing either wild-type MYD88 or MYD88L265P to examine the interplay between MYD88-mediated activation of TAK1 and cytokine secretion and cellular proliferation of malignant B cells. Here, MYD88 is linked to diffuse large B-cell lymphoma.